Tirzepatide drops follow their own separate protocol
Trademark Notice: FeelGood, feelgoodmeds.com, and related marks are the property of FeelGood Health
Amy Rothberg, clinical professor of internal medicine in the Division of Metabolism, Endocrinology and Diabetes at the University of Michigan, says it also helps improve outcomes in people with type 2 diabetes and cardiorenal (heart and kidney) conditions, similar to semaglutide
At the study conclusion, HbA1C and fasting plasma glucose were significantly reduced from baseline with nateglinide [0.5% and 12.6 mg/dl (0.7 mmol/l), respectively] and metformin [0.8% and 28.8 mg/dl (1.6 mmol/l), respectively], but was increased with placebo [0.5% and 7.2 mg/dl (0.4 mmol/l), respectively]
In rare cases, GLP-1 receptor agonists can lead to more serious side effects, such as pancreatitis (inflammation of the pancreas), thyroid tumours, or kidney problems